'Lansley must listen to nurses on the front line' Slow-release insomnia drug shows benefits
A slow-release version of the insomnia drug zolpidem can provide long-term benefits, according to a study.A 25-week trial of 1,018 patients in the US measured total sleep time, number of awakenings and other subjective sleep measures in a placebo group and a group given single-dose extended release zolpidem.The 669 patients in the zolpidem group self-administered 12.5mg of the drug in slow-release form for a minimum of three nights a week to a maximum of seven nights ...
You need to register to view this content
You now need to register for FREE to read our news. Please sign in or register to continue
- Registering is FREE and takes only two minutes
- Registering allows you to read our registered-only news, practice comments and access our Nursing Times Learning units.
- You'll also be able to sign up for our free newsletters
Already registered?
To check that you are registered please enter your email address below
Not registered?
Registration is free and takes just two minutes. After you register, you'll get access to our news stories, competitions and giveaways, newsletters and more.
Not activated?
If you are a registered subscriber you also need to activate your subscription in order to access your subscriber-only content online. This includes free learning units and practice articles.
